Abstract
There are many classes of therapeutic agents whose primary action is on the cardiovascular system. These include antihypertensive drugs (e.g., beta-blocking agents and calcium antagonists), antiarrhythmics (e.g., potassium channel inhibitors), and sympathomimetic drugs (e.g., epinephrine). Other substances, such as ergotamine and vasopressin, are vasoactive and are used for special indications. In addition, other drugs whose primary action is on other organ systems (mainly the central nervous system) such as phenytoin, caffeine, nicotine, and the narcotic drug cocaine also exert pharmacological action on the cardiovascular system as a side effect.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Abrahamsson C, Palmer M, Ljung B, Duker G, Baarnhielm C, Carlsson L, Danielsson B (1994) Induction of rhythm abnormalities in the fetal rat heart. A tentative mechanism for the embryotoxic effect of class III antiarrhythmic agent almoka-lant. Cardiovasc Res 28: 337–344.
Adamsons K, Mueller-Heubach E, Myers RE (1971) Production of fetal asphyxia in the rhesus monkey by administration of catecholamines to the mother. Am J Obstet Gynecol 109: 248–252.
Adolph EF (1965) Capacities for regulation of heart rate in fetal, infant and adult rats. Am J Physiol 209: 1095–1105.
Ariyuki P (1975) Effects of diltiazem hydro-chloride on embryonic development: species differences in the susceptibility and stage specificity in mice, rats, and rabbits. Okajimas Fol Anat Jpn 52: 103–117.
Aselton P, Jick H, Milunsky A, Hunter JR, Stergachis A (1985) First trimester drug use and congenital disorders. Obstet Gynecol 65: 451–455.
Ban Y, Konishi R, Kawana K, Nakatsuka T, Fujii T (1992) Embryotoxic effects of class III antiarrhythmic agent, L-691,121, in rats. Teratology 45: 462.
Bartolomé J, Mills E, Lau C, Slotkin TA (1980) Maturation of sympathetic neurotransmission in the rat heart. V. Development of baroreceptor control of sympathetic tone. J Pharmacol 215: 596–599.
Bertrand M, Girod J, Rigaud MF (1970) Ectrodactylie provoquee par la cafeine chez les rongeurs. Role des facteurs specifiques et genetiques. C R Soc Biol (Paris) 164: 1488–1489.
Bigger TJ, Lefkowitz KJ (1990) Adrenergic receptor antagonists. In: Gilman AG, Rall TW, Nies AS, Taylor P (eds) Goodman and Gilman’s pharmacological basis of therapeutics, 8th edn, vol 2. Pergamon, New York, pp 221–243.
Bingol N, Fuchs M, Diaz V, Stone RK, Gromisch DS (1987) Teratogenicity of cocaine in humans. J Pediatr 110: 93–96.
Bodin N-O, Flodh H, Magnusson G, Malmfors T, Nyberg J-A (1975) Toxicological studies on metoprolol. Acta Pharmacol Toxicol. [Suppl 5] 36: 96–103
Borlee I, Lechat MF, Bouckaert A, Misson C (1978) Coffee, risk factor during pregnancy? Louvain Med 98: 279–284.
Briggs CG, Freeman RK, Yaffe SJ (1990) Drugs in pregnancy and lactation. Williams and Wilkins, Baltimore.
Bruner JP, Forouzan I (1991) Smoking and bucally administered nicotine. Acute effect on uterine artery doppler flow velocity waveforms. J Reprod Med 36: 435–440.
Chasnoff IJ, Griffith DR (1989) Cocaine: clinical studies of pregnancy and the new¬born. Ann NY Acad Sci 562: 260–266.
Chasnoff IJ, Burns WJ, Schnoll SH, Burns KA (1985) Cocaine use in pregnancy. New Engl J Med 313: 666–669.
Chasnoff IJ, Bussey ME, Savich R, Stack CM (1986) Perinatal cerebral infarction and maternal cocaine use. J Pediatr 108: 456–459.
Chasnoff IJ, Chisum GM, Kaplan WE (1988) Maternal cocaine use and genitourinary tract malformations. Teratology 37: 201–204.
Chavez GF, Muliare J, Cordero JF (1988) A population-based study of periconceptional cocaine use and genitourinary tract malformations. Presented at the 9th Annual David W Smith Workshop on Malformations and Morphogenesis, 3–7 August 1988, Oakland, California, p 25.
Chernoff N, Grabowski CT (1971) Responses of the rat fetus to maternal injections of adrenalin and vasopressin. Br J Pharmacol 43: 270–278.
Clark KE, Irion GL (1992) Fetal hemodynamic response to maternal intravenous nicotine administration. Am J Obstet Gynecol 167: 1624–1631.
Collins TFX, Welsh JJ, Black TN, Collins EV (1981) A study of teratogenic potential of caffeine given by oral intubation to rats. Regu Toxicol Pharmacol 1: 355–378.
Couch JR, West C, Hoff HE (1969) Development of the action potential of the prenatal rat heart. Circ Res 24: 19–31.
Danielson MK, Danielsson BRG, Marchner H, Lundin M, Rundqvist E, Reiland S (1992) Histopathological and hemodynamic studies supporting hypoxia and vascular disruption as explanation to phenytoin teratogenicity. Teratology 46: 485–497.
Danielsson BR (1993) Malformations and fetal hypoxia induced by exaggerated pharmacological effects. In: Sundvall A, Danielsson BR, Hagberg O, Lindgren E, Sjöberg P, Victor A (eds) Development toxicology — preclinical and clinical data in retrospect. Tryckgruppen, Stockholm, pp 44–57.
Danielsson BRG, Reiland S, Rundqvist E, Danielson M (1989) Digital defects induced by vaso-dilating agents. Relationship to reduction in utero-placental blood flow. Teratology 40: 351–357.
Danielsson BRG, Reiland S, Rundqvist E, Danielson M, Dencker L, Regård C-G (1990) Histological and in vitro studies supporting decreased utero-placental blood flow as explanation to digital defects after administration of vasodilators. Teratology 41: 185–193.
Danielsson BRG, Danielson M, Rundqvist E, Reiland S (1992) Identical phalangeal defects induced by phenytoin and nifedipine suggest fetal hypoxia and vascular disruption behind phenytoin teratogenicity. Teratology 45: 247–258.
Danielsson BRG, Danielson K, Tomson T (1995) Phenytoin causes phalangeal hypoplasia in the rabbit fetus at clinically relevant free concentrations. Teratology 52: 252–259.
Danielsson BR, Azarbayani F, Wisén AC (1996), Initiation of phenytoin teratogenesis: Pharmacologically induced embryonic bradycardia and arrhythmia resulting in hypoxia/ischemia and possible free radical damage at reperfusion. Teratology 53: 99.
David TJ (1972) Nature and etiology of the Poland anomaly. New Engl J Med 287: 487–489.
Dixon SD, Bejar R (1989) Echoencephalographic finding in neonates associated with maternal cocaine and methamphetamine use: incidence and clinical correlates. J Pediatr 115: 577–778.
Downing SE (1960) Baroreceptor reflexes in new-born rabbit. J Physiol 150: 201–213.
Ducsay CA, Thompson JS, Wu AT et al. (1987) Effects of calcium entry blocker (nicardipine) tocolysis in rhesus macaques: fetal plasma concentrations and cardiorespiratory changes. Am J Obstet Gynecol 157: 1482.
Edgar B, Collste P, Haglund K, Regård CG (1987) Pharmacokinetics and haemodynamic effects of felodipine as monotherapy in hypertensive patients. Clin Invest Med 10: 388–394.
Entman SS, Moise KJ (1984) Anaphylaxis in pregnancy. South Med J 77: 402.
Esaki K (1980) Effects of oral atenolol administration on the rabbit fetus. Preclin Rep Cent Inst Exp Animal 6: 259–264.
Esaki K, Imai K (1980) Effects of oral aternolol on reproduction in rats. Preclin Rep Cent Inst Exp Animal 6: 239–258.
Fantel AG, Barber CV, MacKler B (1992) Ischemia/reperfusion: a new hypothesis for the developmental toxicity of cocaine. Teratology 46: 285–292.
Franklin JB, Brent RL (1964) The effect of uterine vascular clamping on the devel¬opment of rat embryos three to fourteen days old. J Morphol 115: 273–290.
Fukunishi K, Yokoi Y, Yoshida H, Nose T (1980) Effects of nifedipine on rat fetuses (in Japanese). Med Consult N Remed 17: 2245–2256.
Gaily E (1990) Distal phalangeal hypoplasia in children with prenatal phenytoin exposure. Am J Med Genet 35: 403–414.
Gomez H (1958) The development of the innervation of the heart in the rat embryo. Anat Rec 130: 53–71.
Grabowski CT (1970) Embryonic oxygen deficiency — a physiological approach to analysis of teratological mechanisms. In: Woollam DHM (ed) Advances in teratology, vol 9. Logo, London, pp 125–169.
Graham JM Jr, Marin-Padilla M, Hoefnagel D (1983) Jejunal atresia associated with cafergot ingestion during pregnancy. Clin Pediatr (Phila) 22: 226–228.
Grauwiler J, Schon H (1973) Teratological experiments with ergotamine in mice, rats and rabbits. Teratology 7: 227–235.
Greenland VC, Delke I, Minkoff HL (1989) Vaginally administered cocaine overdose in a pregnant women. Obstet Gynecol 74: 476–477.
Greiss FC (1963) The uterine vascular bed: effect of adrenergic stimulation. Obstet Gynecol 21: 295–301.
Hammer RE, Goldman H, Mitchell JA (1981) Effects of nicotine on uterine blood flow and intrauterine oxygen tension in the rat. J Reprod Fertil 63: 163–168.
Hanson JW (1986) Teratogen update: fetal hydantoin effects. Teratology 33: 349–353.
Harake B, Gilbert RD, Ashwal S, Power GG (1987) Nifedipine: effects on fetal and maternal hemodynamics in pregnant sheep. Am J Obstet Gynecol 157: 1003.
Hogg IE (1957) Developing innervation of the heart in the albino rat. Anat Rec. 127: 470 (abst)
Hoyme HE, Jones KL, Dixon SD, Jewett T, Hanson JW, Robinson LK, Msall ME, Allanson JE (1990) Prenatal cocaine exposure and fetal vascular disruption. J Pediatr 85: 743–747.
Hudson BB, Timiras PS (1972) Nicotine injection during gestation: impairment of reproduction, fetal viability, and development. Biol Reprod 7: 247–253.
Hughes HE, Goldstein DA (1988) Birth defects following maternal exposure to ergotamine, beta blockers, and caffeine. J Med Genet 25: 396–399.
Hutchings DE (1993) The puzzle of cocaine’s effect following maternal use during pregnancy: are there reconcilable differences? Neurotoxicol Teratol 15: 282–286.
Infante-Rivard C, Fernández A, Gauthier R, David M, Rivard G-F (1993) Fetal loss associated with caffeine intake before and during pregnancy. JAMA 270: 2940–2943.
Jacobson MF, Goldman AS, Syme RH (1981) Coffee and birth defects. Lancet 1: 1415–1416.
Jones KL (1988) Smith’s recognizable patterns of human malformation. Saunders, Philadelphia, pp 662–705.
Jost A (1951) Sur le role de la vasopressine et de la corticostimuline (ACTH) dans la production experimentale de lesions des extremites foetales (hemorragies, necroses, amputations congenitales). CR Soc Biol (Paris) 145: 1805–1809.
Jost MA (1953) Degenerescence des extremites du foetus de rat provoquée par 1’adrenaline. CR Soc Biol (Paris) 236: 1510–1513.
Kapur RP, Shaw CM, Shepard TH (1991) Brain hemorrhages in cocaine-exposed human fetuses. Teratology 44: 11–18.
Keeler RF (1980) Congenital defects in calfs from maternal ingestion of nicotiana glauca of high anabasine content. Clin Toxicol 15: 417–426.
Kimmel CA, Kimmel GL, White CG, Grafton TF, Young JF, Nelson CJ (1984) Blood flow changes and conceptal development in pregnant rats in response to caffeine. Fundam Appl Toxicol 4: 240–247.
Konoshi R, Ban Y, Kawana T, Nakatsuka, Fujii T (1992) In vitro embryotoxic effects of a class III antiarrhythmic agent L-691,121, in rats using whole embryo culture. Teratology 46: IIB
Ladner C, Weston P, Brinkman CR, Assai NS (1970) Effects of hydralazine on uteroplacental and fetal circulations. Am J Obstet Gynecol 108: 375–381.
Leist KH, Grauwiler J (1973a) Influence of the developmental stage on embryotoxicity following uterine vessel clamping in the rat. Teratology 8: 227–228.
Leist KH, Grauwiler J (1973b) Transplacental passage of 3H ergotamine in the rat and determination of the intraamniotic embryotoxicity of ergotamine. Experientia 29: 764.
Leist KH, Grauwiler J (1974) Fetal pathology in rats following uterine vessel clamping on day 14 of gestation. Teratology 10: 55–68.
Lindblad A, Marsal K, Andersson K-E (1988) Effect of nicotine of human fetal blood flow. Obstet Gynecol 72: 371–382.
Lirette M, Holbrook RH, Katz M (1987) Cardiovascular and uterine blood flow changes during nicardipine HC J tocolysis in the rabbit. Obstet Gynecol 169: 79.
Lundgren Y, Thalen P, Nordlander M (1992) Effects of felodipine on uteroplacental blood flow in normotensive rabbits. Pharmacol Toxicol 71: 361–364.
Lunell NO, Persson B, Aragon G, Fredholm BB, Aström H (1979) Circulatory and metabolic effects of acute beta 1-blockade in severe pre-eclampsia. Acta Obstet Gynecol Scand 58: 443–445.
MacGregor SN, Keith LG, Chasnoff IJ, Rosner MA, Chisum GM, Shaw P, Minogue JP (1987) Cocaine use during pregnancy: adverse perinatal outcome. Obstet Gynecol 157: 686–690.
Martin JD, Young IM (1960) Influence of gestational age and hormones on experimental fetal bradycardia. J Physiol 152: 1–13.
Martin S, Levey BA, Levey GS (1973) Development of betaadrenergic receptor in fetal rat heart. Biochem Biophys Res Commun 54: 949–954.
McClain RM, Langhoff L (1980) Teratogenicity of diphenylhydantoin in the New Zealand white rabbit. Teratology 21: 371–379.
McLean M J, MacDonald RL (1983) Multiple action of phenytoin on mouse spinal cord neurons in cell culture. J Pharmacol Exp Ther 227: 779–798.
Millicovsky G, Johnston MC (1981) Maternal hyperoxia greatly reduces the incidence of phenytoin-induced cleft lip and palate in A/J mice. Science 212: 671–672.
Mills JL, Holmes LB, Aarons JH, Simpson JL, Brown ZA, Jovanovic-Peterson LG, Conley MR, Graubard BI, Knopp RH, Metzger BE (1993) Moderate caffeine use and the risk of spontaneous abortion and intrauterine growth retardation. JAMA 269 5: 593–597.
Moore TR, Sorg J, Miller L, Key TC, Resnik R (1986) Hemodynamic effects of intravenous cocaine on the pregnant ewe and fetus. Am J Obstet Gynecol 155: 883–888.
Morgan MA, Silavin SL, Randolph M, Payne GG, Sheldon RE, Fishburne JI, Wentworth RA, Nathanielsz PW (1991) Effect of intravenous cocaine on uterine blood flow in the gravid baboon. Am J Obstet Gynecol 164: 1021–1030.
Morrow RJ, Ritchie JWK, Bull Sb (1988) Maternal cigarette smoking: the effect on umbilical and uterine blood flow velocity. Am J Obstet Gynecol 159: 1069–1071.
Nehlia A, Derby G (1994) Potential teratogenic and neurodevelopmental consequences of coffee and caffeine exposure; a review on human and animal data. Neurotoxical Teratol 16: 531–543.
Niebyl JR (1988) Drug use in pregnancy, 2nd edn. Lea and Febiger, Philadelphia.
Nishimura H, Nakai K (1958a) Developmental anomalies in offspring of pregnant mice treated with nicotine. Science 127: 877–878.
Nishimura H, Nakai K (1958b) Congenital malformations in offspring of mice treated with caffeine. Proc Soc Exp Biol Med 104: 140–142.
O’Connor PC, Jick H, Hunter JR, Stergachis A, Madsen S (1981) Propranolol and pregnancy outcome. Lancet 2: 1168.
Quigley ME, Sheehan KL, Wilkes MM, Yen SSC (1979) Effects of maternal smoking on circulating catecholamine levels and fetal heart rates. Am J Obstet Gynecol 133: 685–690.
Rall TW (1991) Oxytocin, prostaglandins, ergot alkaloids, and other drugs; tocolytic agents. Chapter 39 In: Gilman AG, Rail TW, Nies AS, Taylor P (eds) Goodman and Gilman’s pharmacological basis of therapeutics, 8th edn, vol 2. Pergamon, New York
Rasmussen HS, Allen MJ, Blackburn KJ, Butrous GS, Dalrymple HW (1992) Dofetilide, a novel class III antiarrhythmic agent. J Cardiovasc Pharmacol 20: S96–S105.
Redmond GP (1982) Propranolol and fetal growth retardation. Semin Perinatol 6: 142–147.
Resnick R, Brink GW, Wilkes M (1979) Catecholamine-mediated reduction in uterine blood flow after nicotine infusion in the pregnant ewe. J Clin Invest 63: 1133–1136.
Robkin M, Shepard TH, Baum D (1973) Autonomic drug effects on the heart rate of rat embryos. Teratology 9: 35–44.
Sandström B (1978) Antihypertensive treatment with the adrenergic beta-receptor blocker metoprolol during pregnancy. Gynecol Invest 9: 195–204.
Schardein JL (1993) Chemically induced birth defects, 2nd edn. Dekker, New York.
Schoenfeld N, Epstein O, Nemesh L, Rosen M, Atsmon A (1978) Effects of propranolol during pregnancy and development of rats. I. Adverse effects during pregnancy. Pediatr Res 12: 747–750.
Schon H, Leist KH, Grauwiler J (1975) Single day treatment of pregnant rats with ergotamine. Teratology 11: 32A.
Sharma A, Plessinger MA, Sherer DM, Liang C, Miller RK, Woods JR (1992) Pregnancy enhances cardiotoxicity of cocaine: role of progesterone. Toxicol Appl Pharmacol 113: 30–35.
Slotkin TA, Lau C, Seidler FJ (1994) β- Adrenergic receptor overexpression in the fetal rats. Distribution, receptor subtypes and coupling to adenylate cyclase activity via G-proteins. Toxicol Appl Pharmacol 129: 223–234.
Spence GS, Vetter C, Hoe C-M (1994) Effects of the class III antiarrhythimic, dofetilide (UK-68,798) on the heart rate of midgestation rat embryos in vitro. Teratology 49: 282–292.
Suzuki K, Minei LJ, Johnson EE (1980) Effect of nicotine upon uterine blood flow in the pregnant rhesus monkey. Am J Obstet Gynecol 136: 1009–1013.
Tcherdakoff PH, Colliard M, Berrard E, Kreft C, Dupay A, Bernaille JM (1978) Propranolol in hypertension during pregnancy. Br Med J 2: 670.
Tomson T, Lindbom U, Ekqvist B, Sundqvist A (1994) Epilepsy and pregnancy: a prospective study of seizure control in relation to free and total plasma concentrations of carbamazepine and pheoytoin. Epilepsia 35,1: 122–130.
Thorley KJ, McAinsh J, Cruickshank JM (1981) Atenolol in the treatment of pregnancy-induced hypertension. Br J Clin Pharmacol 12: 717–730.
Vara P, Kinnunen O (1951) Effect of nicotine on the female rabbit and developing fetus. Ann Med Exp Biol Fenn 29: 202–213.
Watkinson WP, Millicovsky G (1983) Effect of phenytoin on maternal heart rate in A/J mice: possible role in teratogenesis. Teratology 28: 1–8.
Webster WS, Brown-Woodman PDC (1990) Cocaine as a cause of congenital malformations of vascular origin: experimental evidence in the rat. Teratology 41: 689–697.
Webster WS, Lipson AH, Brown-Woodman PDC (1987) Uterine trauma and limb defects. Teratology 35: 253–260.
Webster WS, Brown- Woodman PDC, Lipson AH, Ritchie HE (1991) Fetal brain damage in the rat following prenatal exposure to cocaine. Neurotoxicol Teratol 13: 621–626.
Webster WS, Danielsson BR (1996) Phenytoin- induced bradycardia in rat embryos. Teratology 53: 123.
Webster WS, Brown-Woodman PDC, Snow M, Danielsson BRG (1996) Teratogenic potential of almokalant, dofetilide and d-sotalol: drugs with potassium channel blocking activity. Teratology (in press).
Wide-Swensson D, Ingemarsson I, Arulkumaran S, Andersson K-E (1990) Effects of isradipine, a new calcium antagonist, on maternal cardiovascular system and uterine activity in labour. Br J Obstet Gynaecol 97: 945.
Wildenthal K (1973) Maturation of responsiveness to cardioactive drugs. Differential effects of acetylcholine, norepinephrine, theophylline, tyramine, glucagon, and dibutyryl cyclic AMP on atrial rate in hearts of fetal mice. J Clin Invest 52: 2250
Woods JR, Plessinger MA, Clark KE (1987) Effect of cocaine on uterine blood flow and fetal oxygenation. JAMA 257: 957–961.
Yoshida T, Takegawa Y, Miyago M, Hasegawa Y (1989) Hyperphalangism induced by Ca-blockers in rat fetuses. Teratology 40: 668.
Yaari Y, Selzor ME, Pineus JH (1986) Phenytoin: mechanisms of its anticonvulsant action. Ann Neurol 20: 171–184.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1997 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Danielsson, B.R., Webster, W.S. (1997). Cardiovascular Active Drugs. In: Kavlock, R.J., Daston, G.P. (eds) Drug Toxicity in Embryonic Development II. Handbook of Experimental Pharmacology, vol 124 / 2. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-60447-8_4
Download citation
DOI: https://doi.org/10.1007/978-3-642-60447-8_4
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-64409-2
Online ISBN: 978-3-642-60447-8
eBook Packages: Springer Book Archive